search
Back to results

Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer

Primary Purpose

Colorectal Neoplasms, Neoplasm Metastasis

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Lymph node clearing technique with Carnoy solution
Lymph node clearing technique with GEWF solution
Sponsored by
Hospital Moinhos de Vento
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colorectal Neoplasms focused on measuring Neoplasm Metastasis, Colorectal Neoplasms, Lymph Nodes, Lymph Node Revealing Solution

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Histologically proven colorectal adenocarcinoma
  • Voluntary agreement of the patient to participate in research
  • Voluntary agreement of the surgeon to participate in research

Exclusion Criteria:

  • Absence of accurate histopathological data

Sites / Locations

  • Hospital Moinhos de VentoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Colon Cancer

Rectal Cancer

Arm Description

The subjects in this group will undergo intervention by having surgery and lymph node clearing technique. Intervention A: Carnoy solution Intervention B: GEWF solution

The subjects in this group will undergo intervention by having surgery and lymph node clearing technique. Intervention A: Carnoy solution Intervention B: GEWF solution

Outcomes

Primary Outcome Measures

Lymph nodes harvested
Number of additional lymph nodes harvested with the clearing technique

Secondary Outcome Measures

Lymph node metastasis
Presence of metastasis in the additional lymph nodes harvested
Upstage of lymph nodes
Diagnosis of lymph node metastasis in a patient initially classified as having no lymph node metastasis or increase in the number of metastatic lymph nodes in a patient already staged as having lymph node metastasis.
Adjuvant therapy
Indication of adjuvant therapy as consequence of the upstaging after the lymph nodes clearing technique.

Full Information

First Posted
April 16, 2015
Last Updated
July 8, 2015
Sponsor
Hospital Moinhos de Vento
Collaborators
Federal University of Health Science of Porto Alegre
search

1. Study Identification

Unique Protocol Identification Number
NCT02495532
Brief Title
Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer
Official Title
Randomized Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
July 2015
Overall Recruitment Status
Unknown status
Study Start Date
March 2015 (undefined)
Primary Completion Date
February 2018 (Anticipated)
Study Completion Date
March 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Moinhos de Vento
Collaborators
Federal University of Health Science of Porto Alegre

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Regional lymph node metastasis is a major determinant of local recurrence and overall survival rates in patients with colorectal cancer. Because of the poor prognosis associated with the presence of lymph node metastasis, stage III colorectal cancer patients should receive adjuvant treatment with chemo and / or radiation therapy according to the site of tumor. Several authors have investigated the use of revealing solutions for lymph node clearance in colorectal cancer. Most studies comparing conventional histopathological specimen examination to any lymph node clearing technique showed that the use of revealing solutions increases the mean number of lymph nodes harvested, usually in a statistically significant manner. It is still controversial the impact of the use of revealing solutions for upstaging of lymph node status and consequently for the indication for adjuvant therapy. Therefore will be conducted a randomized clinical trial to compares the performance of GEWF and Carnoy solutions for the histopathological examination of patients with colorectal cancer. The aim of this study is to determine the lymph node revealing solution with the best performance (increase in the mean number of lymph node harvested and lymph node upstaging) in patients with colorectal cancer.
Detailed Description
Patients with histologically proven colorectal adenocarcinoma submitted to curative resection and conventional histopathological examination of the surgical specimen are randomized to undergo further investigation by lymph node clearing technique with Carnoy or GEWF solution.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Neoplasms, Neoplasm Metastasis
Keywords
Neoplasm Metastasis, Colorectal Neoplasms, Lymph Nodes, Lymph Node Revealing Solution

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
126 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Colon Cancer
Arm Type
Active Comparator
Arm Description
The subjects in this group will undergo intervention by having surgery and lymph node clearing technique. Intervention A: Carnoy solution Intervention B: GEWF solution
Arm Title
Rectal Cancer
Arm Type
Active Comparator
Arm Description
The subjects in this group will undergo intervention by having surgery and lymph node clearing technique. Intervention A: Carnoy solution Intervention B: GEWF solution
Intervention Type
Other
Intervention Name(s)
Lymph node clearing technique with Carnoy solution
Other Intervention Name(s)
Carnoy
Intervention Description
Procedure: lymph node clearing technique with Carnoy solution (1) just after the surgical resection each specimen is fixed by formaldehyde; (2) lymph node harvesting is performed by a manual technique of vision and palpation; (3) lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy; (4) the surgical specimen is submitted to re-fixation with Carnoy solution and another lymph node harvesting by manual technique of vision and palpation; (5) additional lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy.
Intervention Type
Other
Intervention Name(s)
Lymph node clearing technique with GEWF solution
Other Intervention Name(s)
GEWF
Intervention Description
Procedure: lymph node clearing technique with GEWF solution (1) just after the surgical resection each specimen is fixed by formaldehyde; (2) lymph node harvesting is performed by a manual technique of vision and palpation; (3) lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy; (4) the surgical specimen is submitted to re-fixation with GEWF solution and another lymph node harvesting by manual technique of vision and palpation; (5) additional lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy.
Primary Outcome Measure Information:
Title
Lymph nodes harvested
Description
Number of additional lymph nodes harvested with the clearing technique
Time Frame
One week
Secondary Outcome Measure Information:
Title
Lymph node metastasis
Description
Presence of metastasis in the additional lymph nodes harvested
Time Frame
One week
Title
Upstage of lymph nodes
Description
Diagnosis of lymph node metastasis in a patient initially classified as having no lymph node metastasis or increase in the number of metastatic lymph nodes in a patient already staged as having lymph node metastasis.
Time Frame
One week
Title
Adjuvant therapy
Description
Indication of adjuvant therapy as consequence of the upstaging after the lymph nodes clearing technique.
Time Frame
One month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Histologically proven colorectal adenocarcinoma Voluntary agreement of the patient to participate in research Voluntary agreement of the surgeon to participate in research Exclusion Criteria: Absence of accurate histopathological data
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tiago L Ghezzi, MD, PhD
Phone
+ 555197256265
Email
tlghezzi@terra.com.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio N Kalil, MD, PhD
Organizational Affiliation
Researcher
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Moinhos de Vento
City
Porto Alegre
State/Province
Rio Grande do Sul
ZIP/Postal Code
90035001
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tiago L Ghezzi, MD, PhD
Phone
+ 555197256265
Email
tlghezzi@terra.com.br

12. IPD Sharing Statement

Learn more about this trial

Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer

We'll reach out to this number within 24 hrs